We have studied the effects of monoclonal antibodies that recognize different epitopes of the cerebellar Ins(1,4,5)P3 receptor on Ins(1,4,5)P3-induced Ca2"-release activity. Ins(1,4,5)P3 stimulated Ca2+ flux from cerebellar microsomes, and half-maximal Ca2+ release occurred at 112+8 nM-Ins ( 
INTRODUCTION
The intracellular Ca2+ concentration is controlled by both Ca2+ influx from the outside of the cell and Ca2+ release from the intracellular Ca2+ storage sites [1, 2] . The voltage-sensitive Ca2+ channels [3] and ligand-gated cation channels [4, 5] located in the plasma membrane have roles in the influx of Ca2+ from outside the cell. Recently, the importance of Ins(1,4,5)P1 generated from polyphosphoinositides in response to receptor stimulation by various kinds of hormones and neurotransmitters has been stressed. Ins (1, 4, 5) P3 is believed to be a second mediator of Ca2+ release from the Ca2+ storage sites [6] [7] [8] . Ins(1,4,5)P3-induced Ca2' release is modulated by various mediators such as ATP [9, 10] , GTP [11] , fatty acids [12] and Ca2+ [13] , and the Ins(1,4,5)P3 receptor is involved in various intracellular phenomena such as Ca2+ 'waves' [14] [15] [16] and Ca2+ oscillations [16] [17] [18] . However, the detailed molecular mechanism of Ca2+ release is unknown because of the paucity of knowledge about the structure of the receptor. Recently we succeeded in purifying the mouse cerebellar Ins(1,4,5)P3 receptor [19] and in cloning its cDNA [20] , and we predicted the primary structure of the receptor. Experiments on transfection with the cerebellar Ins(1,4,5)P3 receptor cDNA revealed that the membrane fraction obtained from the transfected cells has enhanced Ins(1,4,5)P3-binding activity [20] and enhanced Ins(1,4,5)P3-induced Ca2+ release [21] . Furthermore, reconstitution of the purified cerebellar Ins(1,4,5)P3 receptor into planar lipid bilayers [22] demonstrated that the receptor constitutes the cation-selective channel that is opened by Ins(1,4,5)P3 and conducts Na+ and Ca2+. These findings indicate that the cerebellar Ins(1,4,5)P1 receptor is a Ca2+_ permeable cation-selective channel having Ins(1,4,5)P,-binding sites. To study the structure-function relationship of the receptor, we used monoclonal antibodies (mAbs) that recognize different epitopes [19, 20, 23, 24] and examined their effects upon Ca2+ release and Ins(1,4,5)P1 binding. We found that the antibodies that recognize the N-terminus did not affect either Ins(1,4,5)P3 binding or Ca2+ release, but an antibody that recognizes the Cterminus (mAbl8A10) inhibited Ca2+ release, accompanied by reproducibly increased Ins(1,4,5)P, binding without changing the number of Ins(1,4,5)PJ-binding sites. From these findings, together with the precise epitope mapping of mAbl8AI0, we concluded that the C-terminal portion of the receptor plays a crucial role in the regulation of the channel activity of the Ins(1,4,5)P3 receptor.
MATERIALS AND METHODS

Preparation of a cerebeUar microsomal fraction
Adult ddY mice were anaesthetized and killed by decapitation and the cerebella were dissected. Fresh cerebella (10 g) was mixed with 9 vol. of a homogenization buffer containing 0.32 M-sucrose, Teflon-glass Potter homogenizer (10 strokes at 850 rev./min).
The homogenate was centrifuged at 10500 g for 15 min at 2°C, and then the supernatant was collected and the pellet was mixed with 9 vol. of homogenization buffer and homogenized again under the same conditions. The homogenate was centrifuged at 10500 g for 15 min at 2°C, and then the supernatant was collected. The combined supernatants were centrifuged at 105 000 g for 60 min at 2°C to precipitate the microsomal fraction. That fraction was resuspended in a solution containing 0.1 M-sucrose, I mM-EGTA, 0.1 mM-PMSF, 10 /M-leupeptin, 10 ,uM-pepstatin A, 1 mM-DTT and 1O mM-Tris/HCl, pH 7.4, and frozen with liquid N2 in small amounts. The microsomal fraction could be stored at -80°C for at least 1 month without significant loss of Ins(1,4,5)P3-binding activity and Ca2+-release activity.
Measurement of Ins(1,4,5)P3-induced Ca2l release
The microsomal fraction was centrifuged at 105 000 g for 15 min and the pellet was mixed with a Ca2+ mobilization buffer containing 110 mM-KCl, 1 mM-MgCl2, 1 mM-DTT, 10 mM-NaCl, 5 mM-KH2PG4 and 10 mM-Hepes, pH 7.2, and washed three times under the same conditions and then resuspended in the same solution. Ca2+ uptake was initiated by adding 200,1u of microsomal suspension (560-600,ug of protein) into a quartz cuvette containing 1.8 ml of a medium composed of (final concentrations, mM): KC1 1 10, Hepes 10, MgCl2 1, DTT 1, NaCl 10, KH2PO4 5, disodium ATP 1.25 and phosphocreatine 1.25, plus creatine kinase (10 units/ml), oligomycin (2.5 ,ug/ml) and fura-2 free acid (2 4uM), pH 7.2. mAbs were added, and after 15 min of incubation various concentrations of Ins(1,4,5)P3 were tested. The free Ca2+ concentration of the solution was monitored with fura-2 under constant agitation at 30°C in a dual-excitation wavelength RF-5000 spectrofluorimeter (Shimazu Factory, Tokyo, Japan). Changes in fluorescence were monitored at the emission wavelength of 510 nm, with the excitation wavelength alternating between 340 and 380 nm, so that a ratio R of the fluorescence intensities of the dye at both excitation wavelengths could be obtained 30 times/min. The ratio signal was found to be proportional to the free Ca2+ concentration in the cuvette by using Ca2+/EGTA buffers [25] . The actual Ca2+ concentration of the medium was calculated from the maximal fluorescence ratio (Rmax ) [25] .
Preparation of mAbs
The mAbs against theIns(L,4,5)P3 receptor were prepared by injecting partially purified mouse Ins(1,4,5)P3 receptor protein into a rat and fusing the spleen cells with mouse Sp2 myeloma cells, as described previously [23] . The hybridomas were cultured in chemically defined Nissui SFM 101 medium. The culture supernatant was concentrated with an Amicon YM 10 membrane and the IgG was purified by h.p.l.c. on a Bio-Gel HTP column (Bio-Rad). The purified mAbs were dialysed against phosphatebuffered saline (PBS; pH 7.3) and stored at -80 'C. The mAbs used for assay were more than 98 % pure IgG. Synthesis of peptides and coupling to carrier protein Peptides corresponding to the C-terminal region of the Ins(1,4,5)P3 receptor were custom-synthesized on an Applied Biosystems synthesizer, model 430A. The peptides were conjugated to BSA via 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC) as described by Richardson et al. [26] . Briefly, 20 mg of peptide and 20 mg of BSA were dissolved in 5 ml of PBS, pH 7.3, and 20 mg of EDC was added at 4°C with constant stirring. The mixture was stirred overnight. The remaining unreacted EDC and peptides were separated by gel filtration on a Sephadex G-50 column equilibrated in 50 mM-ammonium acetate. The fractions containing peptide-BSA were collected and lyophilized, and then dissolved in PBS.
Immunoblot analysis SDS/PAGE (7.5% gels) was carried out by the method of Laemmli [27] . The proteins were then transferred to a nitrocellulose paper as described by Towbin et al. [28] . The nitrocellulose paper was soaked in 0.5% skim milk in PBS for 30 min at room temperature and then incubated in the mAbl8A10 solution for 30 (Fig. lb) [29] . In the presence of 50 ,ug of mAbl8AO0/ml, there were apparent shifts in the EC50 and the threshold value (Fig. lb) . At the maximal concentration of Ins(1,4,5)P, tested, the presence of mAbl8A10 did not alter the absolute amount of Ca2+ released from the microsomal fraction (Fig. lb) (Fig. 3) . From these experiments, the relative affinity of each antibody to its epitope could be determined. The order of the affinities of these antibodies with the receptor was lOA6 > 4CI 1 = 1 8A10, indicating that the affinity of mAbl8A10 was not greater than that of the others.
Thus the inhibitory effect of mAbl8A10 on Ins(l ,4,5)P3-induced Ca2+ release is presumably due to its binding to an important site for channel activity. [3H]Ins(1,4,5)P3 ( Microsomal fractions were incubated with 50 ,ug of mAbl8A10/ml for 2 h on ice. Binding assays contained 24 Each well of a 96-well microtitre plate was coated with 100 #1 of purified Ins(1,4,5)P3 receptor (1 jg/ml). Various amounts of peptides (-, pep6; 0, pepl; *, pep2; O, pep3; A, pep4; A, pep5; r1, no peptide) were mixed with 100 ,ul of mAbl8A10 (0.4 /zg/ml) and the mixtures were added to the wells. After incubation for 30 min at room temperature, biotinylated anti-(rat IgG) antibody was introduced to each well. Avidin and biotinylated horseradishperoxidase complex were sequentially added, and o-phenylenediamine dihydrochloride was used as the substrate. The colour intensity given by the product was monitored at 480 nm with a Micro Plate Reader.
Epitope mapping for mAbl8A10
From the sequence analysis of the immunopositive clones of the Ins(1,4,5)P3 receptor, we previously predicted that the epitope of mAbl8AI0 was located within amino acid residues 2648-2749 (C-terminal end) of the Ins(1,4,5)P3 receptor ([20] , Fig. 6 ). To obtain further information about the precise sequence that mAbl8AI0 recognizes, we carried out epitope mapping by using synthetic short peptides within residues 2648-2749. The six synthetic peptides shown in Fig. 6 were each conjugated with BSA. The six peptide-BSA conjugates were examined for binding to mAbl8Al0 by Western blotting. A positive reaction was observed only with pep6-BSA (covering residues 2736-2747, lane c in Fig. 7 ), and not with the other five peptide-BSA conjugates or with BSA itself. A competitive e.l.i.s.a. clearly showed that pep6 inhibited the binding of mAbl8A10 to the purified Ins(1,4,5)P3 receptor (Fig. 8) . However, the other peptides did not compete with the purified Ins(1,4,5)P3 receptor for binding to mAbl 8AO0. These results indicate that the epitope of mAbl8Al0 is located within pep6, a 12-residue-long peptide with the sequence Gly-His-Pro-Pro-His-Met-Asn-Val-Asn-ProGln-Gln (residues 2736-2747 of the receptor).
DISCUSSION
The cerebellar Ins(1,4,5)P3 receptor is a large membranebound glycoprotein of 320 kDa (313 kDa, as deduced from its amino acid sequence [20] ; SDS/PAGE estimate of 250 kDa [19] , agarose/PAGE estimate of 320 kDa [22] ). The hydropathy profile of the amino acid sequence of the Ins(1,4,5)P3 receptor indicates that it is a unique protein composed of the large N-terminal domain, the membrane-spanning domains clustered near the C-terminus and the short C-terminal domain [20] . A transfection experiment with a mutant in which the 3'-portion of the cDNA is deleted demonstrated that the mutant protein is recovered in the soluble fraction, indicating that the C-terminal region has a membrane-anchoring action [30] . Recently it has been demonstrated that the cerebellar Ins(1,4,5)P3 receptor itself has Ca2+-release-channel activity, revealed by the liposome vesicle system [31] and the planar lipid bilayer system [22] . A crosslinking experiment showed that the Ins(1,4,5)P3 receptor forms a tetrameric structure [22] , and this finding corresponds well with the negative staining image obtained by electron microscopy [19] . Since the C-terminus is near the membrane-spanning domains of four subunits which seem to form a single membrane pore, we examined how the C-terminal portion of the receptor is involved in Ca2+ release by using mAbs. mAbl8Al0 had two effects. It [33] . Similar results were reported recently by Satoh et al. [34] . As for the topology of the receptor on the SER membrane, we concluded that both N-and C-termini are on the cytoplasmic side of the SER [33] , since the epitopes recognized by the three mAbs were all located on the side. This is consistent with our finding that mAbl8A10 interfered with the Ca2+- [39] , but they also act as general Ca2+ antagonists on the Ca2+ channel located in the plasma membrane or intracellular vesicle. Heparin is also a wellknown inhibitor of Ins(1,4,5)P3 binding to the receptor and it suppresses Ins(1,4,5)P3-induced Ca2+ release [40] . However, it is not a specific inhibitor of the Ins(1,4,5)P3 receptor. Heparin exerts a variety of effects, because there are numerous heparinbinding proteins in the cell. In this sense, mAbI 8A10 is considered to be a specific molecule that recognizes the Ins(1,4,5)P3 receptor and changes the Ins(1,4,5)P3-induced Ca2+-release and Ins(1,4,5)P3-binding activities.
Antibodies against the various regions of the receptor will give us more information on its structure and function. Addition of mAbs to cultured cells will give us information about the physiological role of the Ins(1,4,5)P3 receptor.
